Search

everythinglearnresearchcommunity

for

Search:↓

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

ChatGPT 4.0 and Gemini 1.5 Flash are effective for educating patients about androgenetic alopecia, while Deepseek R1 is less reliable.

JAK inhibitors like baricitinib are a new FDA-approved treatment for alopecia areata, but safety data is incomplete.

Overexpression of ALK2 in hair follicles disrupts skin development and slows wound healing.

XEDAR deficiency prevents muscle degeneration in EDA-A2 transgenic mice.

Tofacitinib helped a patient regrow hair after 40 years of total hair loss.

Autologous Micrografting Technology effectively improves hair growth and is a safe, promising option for hair restoration.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.

JAK inhibitors are effective in treating various immune-related diseases, not just rheumatoid arthritis.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

AUC and APL are distinct conditions needing careful clinical assessment.

The new deep learning system can accurately recognize hair loss conditions with a 95.11% success rate.

Chinese patients with alopecia areata value JAK inhibitors but worry about side effects and relapse, highlighting the need for education and support.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.

Using Janus kinase inhibitors (JAKi) in COVID-19 treatment requires careful consideration due to their immunosuppressive effects.

Combining triamcinolone acetonide and immunotherapy can help regrow hair in some alopecia totalis patients.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

Scientists found a gene in mice that causes early hearing loss.

Mice without the Sept4/ARTS gene heal wounds better due to more stem cells that don't die easily.

A specific type of immune cell plays a key role in causing alopecia areata and could be a target for treatment.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Blocking autophagy increases survival of inner ear hair cells exposed to gentamicin.

Precision neuromodulation may improve schizophrenia symptoms.